Effects of dairy protein and fat on the metabolic syndrome and type 2 diabetes

Review of Diabetic Studies

Volumn 11, Issue 2, 2014, Pages 153-166

  Bjørnshave, Ann ^a   Hermansen, Kjeld ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood pressure; Dairy fat; Glucose metabolism; Lipid metabolism; Metabolic syndrome; Type 2 diabetes

Indexed keywords

CASEIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; FAT; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MILK PROTEIN; PROSTACYCLIN; TOLL LIKE RECEPTOR 4; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; FAT INTAKE; FATTY ACID; GLUCOSE BLOOD LEVEL; MONOUNSATURATED FATTY ACID; PHOSPHOLIPID; UNSATURATED FATTY ACID; WHEY PROTEIN;

BLOOD PRESSURE REGULATION; CARDIOMETABOLIC RISK; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DRUG EFFECT; DRUG RESPONSE; FAT INTAKE; FERMENTED PRODUCT; GLUCOSE METABOLISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; INSULIN LIKE ACTIVITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID DIET; LIPID METABOLISM; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POSTMENOPAUSE; POSTPRANDIAL STATE; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASODILATATION; ADMINISTRATION AND DOSAGE; BLOOD; BLOOD PRESSURE; DAIRY PRODUCT; DIABETES MELLITUS, TYPE 2; DIET; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; MEDLINE; METABOLISM; PATHOPHYSIOLOGY;

BLOOD GLUCOSE; BLOOD PRESSURE; CASEINS; DAIRY PRODUCTS; DIABETES MELLITUS, TYPE 2; DIET; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; HUMANS; INSULIN; LIPID METABOLISM; MEDLINE; METABOLIC SYNDROME X; MILK PROTEINS; PHOSPHOLIPIDS; WHEY PROTEINS;

EID: 84908056184     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2014.11.153     Document Type: Review

References (105)

1. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006. 23(5):469-480.
2. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006. 119(10):812-819.
3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009. 120(16):1640-1645.
4. Crichton GE, Bryan J, Buckley J, Murphy KJ. Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues. Obes Rev 2011. 12(5):e190-e201.
5. Pfeuffer M, Schrezenmeir J. Milk and the metabolic syndrome. Obes Rev 2007. 8(2):109-118.
6. Tong X, Dong JY, Wu ZW, Li W, Qin LQ. Dairy consumption and risk of type 2 diabetes mellitus: a metaanalysis of cohort studies. Eur J Clin Nutr 2011. 65(9):1027-1031.
7. Kalergis M, Leung Yinko SS, Nedelcu R. Dairy products and prevention of type 2 diabetes: implications for research and practice. Front Endocrinol (Lausanne) 2013. 4:90.
8. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 2013. 98(4):1066-1083.
9. Panagiotakos DB, Pitsavos CH, Zampelas AD, Chrysohoou CA, Stefanadis CI. Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults: the ATTICA study. J Am Coll Nutr 2010. 29(4):357-364.
10. Djousse L, Pankow JS, Hunt SC, Heiss G, Province MA, Kabagambe EK, Ellison RC. Influence of saturated fat and linolenic acid on the association between intake of dairy products and blood pressure. Hypertension 2006. 48(2):335-341.
11. Chrysant SG, Chrysant GS. An update on the cardiovascular pleiotropic effects of milk and milk products. J Clin Hypertens (Greenwich) 2013. 15(7):503-510.
12. Sluijs I, Forouhi NG, Beulens JW, van der Schouw YT, Agnoli C, Arriola L, Balkau B, Barricarte A, Boeing H, Bueno-de-Mesquita HB, et al. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr 2012. 96(2):382-390.
13. O’Connor LM, Lentjes MA, Luben RN, Khaw KT, Wareham NJ, Forouhi NG. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia 2014. 57(5):909-917.
14. Da Silva MS, Rudkowska I. Dairy products on metabolic health: current research and clinical implications. Maturitas 2014. 77(3):221-228.
15. Smithers GW. Whey and whey proteins - from ‘gutter-togold’. Int Dairy J 2008. 18(7):695-704.
16. Sousa GT, Lira FS, Rosa JC, de Oliveira EP, Oyama LM, Santos RV, Pimentel GD. Dietary whey protein lessens several risk factors for metabolic diseases: a review. Lipids Health Dis 2012. 11:67.
17. Pal S, Radavelli-Bagatini S. The effects of whey protein on cardiometabolic risk factors. Obes Rev 2013. 14(4):324-343.
18. McGregor RA, Poppitt SD. Milk protein for improved metabolic health: a review of the evidence. Nutr Metab (Lond) 2013. 10(1):46.
19. Bendtsen LQ, Lorenzen JK, Bendsen NT, Rasmussen C, Astrup A. Effect of dairy proteins on appetite, energy expenditure, body weight, and composition: a review of the evidence from controlled clinical trials. Adv Nutr 2013. 4(4):418-438.
20. Foegeding EA, Luck P, Vardhanabhuti B. Whey Protein Products. In: Encyclopedia of Dairy Science. Elsevier, 2011. Chapter 873-878.
21. Ricci-Cabello I, Herrera MO, Artacho R. Possible role of milk-derived bioactive peptides in the treatment and prevention of metabolic syndrome. Nutr Rev 2012. 70(4):241-255.
22. Morifuji M, Ishizaka M, Baba S, Fukuda K, Matsumoto H, Koga J, Kanegae M, Higuchi M. Comparison of different sources and degrees of hydrolysis of dietary protein: effect on plasma amino acids, dipeptides, and insulin responses in human subjects. J Agric Food Chem 2010. 58(15):8788-8797.
23. Petersen BL, Ward LS, Bastian ED, Jenkins AL, Campbell J, Vuksan V. A whey protein supplement decreases post-prandial glycemia. Nutr J 2009. 8:47.
24. Pal S, Ellis V. The acute effects of four protein meals on insulin, glucose, appetite and energy intake in lean men. Br J Nutr 2010. 104(8):1241-1248.
25. Akhavan T, Luhovyy BL, Brown PH, Cho CE, Anderson GH. Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. Am J Clin Nutr 2010. 91(4):966-975.
26. Akhavan T, Luhovyy BL, Panahi S, Kubant R, Brown PH, Anderson GH. Mechanism of action of premeal consumption of whey protein on glycemic control in young adults. J Nutr Biochem 2014. 25(1):36-43.
27. Frid AH, Nilsson M, Holst JJ, Bjorck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr 2005. 82(1):69-75.
28. Acheson KJ, Blondel-Lubrano A, Oguey-Araymon S, Beaumont M, Emady-Azar S, Ammon-Zufferey C, Monnard I, Pinaud S, Nielsen-Moennoz C, Bovetto L. Protein choices targeting thermogenesis and metabolism. Am J Clin Nutr 2011. 93(3):525-534.
29. Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones KL, Clifton PM, Horowitz M, Rayner CK. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 2009. 32(9):1600-1602.
30. Belobrajdic DP, McIntosh GH, Owens JA. A highwhey-protein diet reduces body weight gain and alters insulin sensitivity relative to red meat in wistar rats. J Nutr 2004. 134(6):1454-1458.
31. Pal S, Ellis V, Dhaliwal S. Effects of whey protein isolate on body composition, lipids, insulin and glucose in overweight and obese individuals. Br J Nutr 2010. 104(5):716-723.
32. Nilsson M, Holst JJ, Bjorck IM. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr 2007. 85(4):996-1004.
33. Liu Z, Jeppesen PB, Gregersen S, Chen X, Hermansen K. Dose- and glucose-dependent ffects of amino acids on insulin secretion from isolated mouse islets and clonal INS-1E beta-cells. Rev Diabet Stud 2008. 5(4):232-244.
34. Jakubowicz D, Froy O. Biochemical and metabolic mechanisms by which dietary whey protein may combat obesity and type 2 diabetes. J Nutr Biochem 2013. 24(1):1-5.
35. Melnik BC. Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J Diabetes 2012. 3(3):38-53.
36. Freudenberg A, Petzke KJ, Klaus S. Comparison of high-protein diets and leucine supplementation in the prevention of metabolic syndrome and related disorders in mice. J Nutr Biochem 2012. 23(11):1524-1530.
37. Phillips LK, Prins JB. Update on incretin hormones. Ann N Y Acad Sci 2011. 1243:E55-E74.
38. Nilsson M, Stenberg M, Frid AH, Holst JJ, Bjorck IM. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr 2004. 80(5):1246-1253.
39. Holmer-Jensen J, Mortensen LS, Astrup A, de VM, Holst JJ, Thomsen C, Hermansen K. Acute differential effects of dietary protein quality on postprandial lipemia in obese non-diabetic subjects. Nutr Res 2013. 33(1):34-40.
40. Mortensen LS, Hartvigsen ML, Brader LJ, Astrup A, Schrezenmeir J, Holst JJ, Thomsen C, Hermansen K. Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein. Am J Clin Nutr 2009. 90(1):41-48.
41. Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 2003. 89(2):239-248.
42. Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A, van Vught AJ, Westerterp KR, Engelen MP, Brummer RJ, Deutz NE, Westerterp-Plantenga MS. Dose-dependent satiating effect of whey relative to casein or soy. Physiol Behav 2009. 96(4-5):675-682.
43. Olivos DR, McGrath LE, Turner CA, Montaubin O, Mietlicki-Baase EG, Hayes MR. Intraduodenal milk protein concentrate augments the glycemic and food intake suppressive effects of DPP-IV inhibition. Am J Physiol Regul Integr Comp Physiol 2014. 306(3):R157-R163.
44. Lacroix IM, Li-Chan EC. Inhibition of dipeptidyl peptidase (DPP)-IV and alpha-glucosidase activities by pepsintreated whey proteins. J Agric Food Chem 2013. 61(31):7500-7506.
45. Silveira ST, Martinez-Maqueda D, Recio I, Hernandez-Ledesma B. Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in beta-lactoglobulin. Food Chem 2013. 141(2):1072-1077.
46. Mortensen LS, Holmer-Jensen J, Hartvigsen ML, Jensen VK, Astrup A, de VM, Holst JJ, Thomsen C, Hermansen K. Effects of different fractions of whey protein on postprandial lipid and hormone responses in type 2 diabetes. Eur J Clin Nutr 2012. 66(7):799-805.
47. Holmer-Jensen J, Hartvigsen ML, Mortensen LS, Astrup A, de VM, Holst JJ, Thomsen C, Hermansen K. Acute differential effects of milk-derived dietary proteins on postprandial lipaemia in obese non-diabetic subjects. Eur J Clin Nutr 2012. 66(1):32-38.
48. Claessens M, van Baak MA, Monsheimer S, Saris WH. The effect of a low-fat, high-protein or highcarbohydrate ad libitum diet on weight loss maintenance and metabolic risk factors. Int J Obes (Lond) 2009. 33(3):296-304.
49. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999. 246(4):341-355.
50. Hlais S, Reslan DR, Sarieddine HK, Nasreddine L, Taan G, Azar S, Obeid OA. Effect of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, openlabel, randomized, placebo-controlled trial. Clin Ther 2012. 34(8):1674-1682.
51. Freudenberg A, Petzke KJ, Klaus S. Dietary L-leucine and L-alanine supplementation have similar acute effects in the prevention of high-fat diet-induced obesity. Amino Acids 2013. 44(2):519-528.
52. Fekete AA, Givens DI, Lovegrove JA. The impact of milk proteins and peptides on blood pressure and vascular function: a review of evidence from human intervention studies. Nutr Res Rev 2013. 26(2):177-190.
53. Pal S, Ellis V, Ho S. Acute effects of whey protein isolate on cardiovascular risk factors in overweight, postmenopausal women. Atherosclerosis 2010. 212(1):339-344.
54. Pal S, Ellis V. The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity (Silver Spring) 2010. 18(7):1354-1359.
55. Lee YM, Skurk T, Hennig M, Hauner H. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur J Nutr 2007. 46(1):21-27.
56. Ballard KD, Bruno RS, Seip RL, Quann EE, Volk BM, Freidenreich DJ, Kawiecki DM, Kupchak BR, Chung MY, Kraemer WJ, et al. Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: a randomized, placebo controlled trial. Nutr J 2009. 8:34.
57. Ballard KD, Kupchak BR, Volk BM, Mah E, Shkreta A, Liptak C, Ptolemy AS, Kellogg MS, Bruno RS, Seip RL, et al. Acute effects of ingestion of a novel wheyderived extract on vascular endothelial function in overweight, middle-aged men and women. Br J Nutr 2013. 109(5):882-893.
58. Fluegel SM, Shultz TD, Powers JR, Clark S, Barbosa-Leiker C, Wright BR, Freson TS, Fluegel HA, Minch JD, Schwarzkopf LK, et al. Whey beverages decrease blood pressure in prehypertensive and hypertensive young men and women. Int Dairy J 2010. 20(11):753-760.
59. Pins JJ, Keenan JM. Effects of whey peptides on cardiovascular disease risk factors. J Clin Hypertens (Greenwich) 2006. 8(11):775-782.
60. Calbet JA, Holst JJ. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr 2004. 43(3):127-139.
61. Arnberg K, Molgaard C, Michaelsen KF, Jensen SM, Trolle E, Larnkjaer A. Skim milk, whey, and casein increase body weight and whey and casein increase the plasma C-peptide concentration in overweight adolescents. J Nutr 2012. 142(12):2083-2090.
62. Jonker JT, Wijngaarden MA, Kloek J, Groeneveld Y, Gerhardt C, Brand R, Kies AK, Romijn JA, Smit JW. Effects of low doses of casein hydrolysate on post-challenge glucose and insulin levels. Eur J Intern Med 2011. 22(3):245-248.
63. Geerts BF, van Dongen MG, Flameling B, Moerland MM, de Kam ML, Cohen AF, Romijn JA, Gerhardt CC, Kloek J, Burggraaf J. Hydrolyzed casein decreases postprandial glucose concentrations in T2DM patients irrespective of leucine content. J Diet Suppl 2011. 8(3):280-292.
64. Brader L, Holm L, Mortensen L, Thomsen C, Astrup A, Holst JJ, de VM, Schrezenmeir J, Hermansen K. Acute effects of casein on postprandial lipemia and incretin responses in type 2 diabetic subjects. Nutr Metab Cardiovasc Dis 2010. 20(2):101-109.
65. Weisse K, Brandsch C, Zernsdorf B, Nkengfack Nembongwe GS, Hofmann K, Eder K, Stangl GI. Lupin protein compared to casein lowers the LDL cholesterol: HDL cholesterol-ratio of hypercholesterolemic adults. Eur J Nutr 2010. 49(2):65-71.
66. Turpeinen AM, Jarvenpaa S, Kautiainen H, Korpela R, Vapaatalo H. Antihypertensive effects of bioactive tripeptides-a random effects meta-analysis. Ann Med 2013. 45(1):51-56.
67. Cicero AF, Aubin F, Azais-Braesco V, Borghi C. Do the lactotripeptides isoleucine-proline-proline and valineproline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am J Hypertens 2013. 26(3):442-449.
68. Townsend RR, McFadden CB, Ford V, Cadee JA. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am J Hypertens 2004. 17(11 Pt 1):1056-1058.
69. Cadee JA, Chang CY, Chen CW, Huang CN, Chen SL, Wang CK. Bovine casein hydrolysate (c12 Peptide) reduces blood pressure in prehypertensive subjects. Am J Hypertens 2007. 20(1):1-5.
70. Riserus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009. 48(1):44-51.
71. Kratz M, Baars T, Guyenet S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr 2013. 52(1):1-24.
72. Givens DI. Milk in the diet: good or bad for vascular disease? Proc Nutr Soc 2012. 71(1):98-104.
73. Huth PJ, Park KM. Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence. Adv Nutr 2012. 3(3):266-285.
74. Jensen RG. The composition of bovine milk lipids: January 1995 to December 2000. J Dairy Sci 2002. 85(2):295-350.
75. Mansson HL. Fatty acids in bovine milk fat. Food Nutr Res 2008. 2008:52.
76. Belitz HD, Grosch W, Schieberle P. Milk and Dairy Products. In: Food Chemistry. 2008, Chapter 10, pp 498-545.
77. Mason P, Porter SC, Berry SE, Stillman P, Steele C, Kirby A, Griffin BA, Minihane AM. Saturated fatty acid consumption: outlining the scale of the problem and assessing the solutions. Nutr Bull 2009. 34(1):74-84.
78. Kennedy A, Martinez K, Chuang CC, LaPoint K, McIntosh M. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr 2009. 139(1):1-4.
79. Kuipers RS, de Graaf DJ, Luxwolda MF, Muskiet MH, Dijck-Brouwer DA, Muskiet FA. Saturated fat, carbohydrates and cardiovascular disease. Neth J Med 2011. 69(9):372-378.
80. Hays JH, Gorman RT, Shakir KM. Results of use of metformin and replacement of starch with saturated fat in diets of patients with type 2 diabetes. Endocr Pract 2002. 8(3):177-183.
81. Phillips CM, Goumidi L, Bertrais S, Field MR, McManus R, Hercberg S, Lairon D, Planells R, Roche HM. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome. J Nutr Biochem 2012. 23(3):239-244.
82. Cuda C, Badawi A, Karmali M, El-Sohemy A. Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol. Metabolism 2011. 60(8):1131-1135.
83. Carrel G, Egli L, Tran C, Schneiter P, Giusti V, D’Alessio D, Tappy L. Contributions of fat and protein to the incretin effect of a mixed meal. Am J Clin Nutr 2011. 94(4):997-1003.
84. Funaki M. Saturated fatty acids and insulin resistance. J Med Invest 2009. 56(3-4):88-92.
85. German JB, Gibson RA, Krauss RM, Nestel P, Lamarche B, van Staveren WA, Steijns JM, de Groot LC, Lock AL, Destaillats F. A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur J Nutr 2009. 48(4):191-203.
86. Deevska GM, Nikolova-Karakashian MN. The twists and turns of sphingolipid pathway in glucose regulation. Biochimie 2011. 93(1):32-38.
87. Masson CJ, Mensink RP. Exchanging saturated fatty acids for (n-6) polyunsaturated fatty acids in a mixed meal may decrease postprandial lipemia and markers of inflammation and endothelial activity in overweight men. J Nutr 2011. 141(5):816-821.
88. Marten B, Pfeuffer M, Schrezenmeir J. Medium-chain triglycerides. Int Dairy J 2006. 16(11):1374-1382.
89. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003. 77(5):1146-1155.
90. Werner LB, Hellgren LI, Raff M, Jensen SK, Petersen RA, Drachmann T, Tholstrup T. Effects of butter from mountain-pasture grazing cows on risk markers of the metabolic syndrome compared with conventional Danish butter: a randomized controlled study. Lipids Health Dis 2013. 12:99.
91. Hjerpsted J, Leedo E, Tholstrup T. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am J Clin Nutr 2011. 94(6):1479-1484.
92. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, Siscovick DS, Nettleton JA. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2013. 97(4):854-861.
93. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 2010. 153(12):790-799.
94. Gunnarsson PT, Winzell MS, Deacon CF, Larsen MO, Jelic K, Carr RD, Ahren B. Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice. Endocrinology 2006. 147(7):3173-3180.
95. Fonolla J, Lopez-Huertas E, Machado FJ, Molina D, Alvarez I, Marmol E, Navas M, Palacin E, Garcia-Valls MJ, Remon B, et al. Milk enriched with "healthy fatty acids" improves cardiovascular risk markers and nutritional status in human volunteers. Nutrition 2009. 25(4):408-414.
96. Benito P, Caballero J, Moreno J, Gutierrez-Alcantara C, Munoz C, Rojo G, Garcia S, Soriguer FC. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 2006. 25(4):581-587.
97. Riserus U, Smedman A, Basu S, Vessby B. Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am J Clin Nutr 2004. 79(6 Suppl):1146S-1148S.
98. Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. Conjugated linoleic acid increased C-reactive protein in human subjects. Br J Nutr 2005. 94(5):791-795.
99. Sofi F, Buccioni A, Cesari F, Gori AM, Minieri S, Mannini L, Casini A, Gensini GF, Abbate R, Antongiovanni M. Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: a dietary intervention study. Nutr Metab Cardiovasc Dis 2010. 20(2):117-124.
100. Contarini G, Povolo M. Phospholipids in milk fat: composition, biological and technological significance, and analytical strategies. Int J Mol Sci 2013. 14(2):2808-2831.
101. Eckhardt ER, Wang DQ, Donovan JM, Carey MC. Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology 2002. 122(4):948-956.
102. Ohlsson L, Burling H, Duan RD, Nilsson A. Effects of a sphingolipid-enriched dairy formulation on postprandial lipid concentrations. Eur J Clin Nutr 2010. 64(11):1344-1349.
103. Keller S, Malarski A, Reuther C, Kertscher R, Kiehntopf M, Jahreis G. Milk phospholipid and plant sterol-dependent modulation of plasma lipids in healthy volunteers. Eur J Nutr 2013. 52(3):1169-1179.
104. Conway V, Couture P, Richard C, Gauthier SF, Pouliot Y, Lamarche B. Impact of buttermilk consumption on plasma lipids and surrogate markers of cholesterol homeostasis in men and women. Nutr Metab Cardiovasc Dis 2013. 23(12):1255-1262.
105. Conway V, Couture P, Gauthier S, Pouliot Y, Lamarche B. Effect of buttermilk consumption on blood pressure in moderately hypercholesterolemic men and women. Nutrition 2014. 30(1):116-119.